A large number of mature and functional dendritic cells can be efficiently generated from umbilical cord blood-derived mononuclear cells by a simple two-step culture method

被引:22
作者
Balan, Sreekumar [1 ]
Kale, Vaijayanti P. [1 ]
Limaye, Lalita S. [1 ]
机构
[1] Pune Univ Campus, Lab 4, Natl Ctr Cell Sci, Pune 411007, Maharashtra, India
关键词
COLONY-STIMULATING FACTOR; CD34(+) PROGENITOR CELLS; CYTOTOXIC T-LYMPHOCYTES; CANCER-IMMUNOTHERAPY; G-CSF; BONE-MARROW; TUMOR; VACCINATION; MELANOMA; MONOCYTES;
D O I
10.1111/j.1537-2995.2010.02706.x
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
BACKGROUND: Advances in the past two decades in dendritic cell (DC) biology paved the way to exploit them as a promising tool in cancer immunotherapy. The prerequisite for DC vaccine preparations is large-scale in vitro generations of homogeneous, mature, and functional DCs Frequent improvements are being made in the existing in vitro DC production protocols to achieve this goal. In our previous study we reported a large-scale generation of mature, functional DCs from umbilical cord blood (UCB) CD34+ cells. Here we report that this method can be used for the efficient generation of DCs from UCB mononuclear cells (MNCs) and thus the hematopoietic stem cell isolation step is not essential. STUDY DESIGN AND METHODS: MNCs or CD34+ cells isolated from the same cord blood (CB) samples were used for the generation of DCs DCs were characterized for morphology, phenotype, and functional assays including antigen uptake, chemotaxis, and mixed leukocyte reaction. Similarly DCs generated from the MNCs of same fresh and frozen CB units were compared. RESULTS: The morphologic, phenotypic, and functional characterization of the DCs generated from various sets show that they were comparable in nature irrespective of the starting population used. CONCLUSION: We conclude that the CD34+ isolation step is not essential for the generation of mature, functional DCs and thus can be eliminated. More importantly, we show that DCs can be generated with equal efficiency from the MNCs of frozen CB units. Our culture method will be useful for exploiting the potential of UCB as an additional source for allogeneic DCs in the clinical settings.
引用
收藏
页码:2413 / 2423
页数:11
相关论文
共 45 条
[1]
Dendritic cells: still a promising tool for cancer immunotherapy [J].
Aragoneses-Fenoll, L. ;
Corbi, A. L. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2007, 9 (02) :77-82
[2]
Long-term culture of human CD34+ progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34-CD14- and a CD34-CD14+ dendritic cell precursor [J].
Arrighi, JF ;
Hauser, C ;
Chapuis, B ;
Zubler, RH ;
Kindler, V .
BLOOD, 1999, 93 (07) :2244-2252
[3]
Phase I/II study of vaccination with electrofused allogeneic dendritic Cells/Autologous tumor-derived cells in patients with stage IV renal cell carcinoma [J].
Avigan, David E. ;
Vasir, Baldev ;
George, Daniel J. ;
Oh, William K. ;
Atkins, Michael B. ;
McDermott, David F. ;
Kantoff, Philip W. ;
Figlin, Robert A. ;
Vasconcelles, Michael J. ;
Xu, Yuanxin ;
Kufe, Donald ;
Bukowski, Ronald M. .
JOURNAL OF IMMUNOTHERAPY, 2007, 30 (07) :749-761
[4]
A simple two-step culture system for the large-scale generation of mature and functional dendritic cells from umbilical cord blood CD34+cells [J].
Balan, Sreekumar ;
Kale, Vaijayanti P. ;
Limaye, Lalita S. .
TRANSFUSION, 2009, 49 (10) :2109-2121
[5]
Racial diversity with high nucleated cell counts and CD34 counts achieved in a national network of cord blood banks [J].
Ballen, KK ;
Kurtzberg, J ;
Lane, TA ;
Lindgren, BR ;
Miller, JP ;
Nagan, D ;
Newman, B ;
Rupp, N ;
Haley, NR .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (04) :269-275
[6]
Bontkes HJ, 2002, J LEUKOCYTE BIOL, V72, P321
[7]
Dendritic cells can be successfully generated from CD34+ cord blood cells in the presence of autologous cord blood plasma [J].
Borràs, FE ;
Matthews, NC ;
Patel, R ;
Navarrete, C .
BONE MARROW TRANSPLANTATION, 2000, 26 (04) :371-376
[8]
Umbilical cord blood transplantation: Basic biology and clinical challenges to immune reconstitution [J].
Brown, Julia A. ;
Boussiotis, Vassiliki A. .
CLINICAL IMMUNOLOGY, 2008, 127 (03) :286-297
[9]
CD34(+) hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha [J].
Caux, C ;
Vanbervliet, B ;
Massacrier, C ;
DezutterDambuyant, C ;
deSaintVis, B ;
Jacquet, C ;
Yoneda, K ;
Imamura, S ;
Schmitt, D ;
Banchereau, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :695-706
[10]
Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines [J].
de Gruijl, Tanja D. ;
van den Eertwegh, Alfons J. M. ;
Pinedo, Herbert M. ;
Scheper, Rik J. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (10) :1569-1577